Key facts
- This page summarizes Mark Eisner's Form 4 filing for FIBROGEN INC (FGEN).
- 5 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Mar 2023, 20:55.
Mark Eisner - 08 Mar 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- FGEN
- Reported as of
- 08 Mar 2023
- Net transaction value
- -$360,572
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2023, 20:55:04 UTC
- Prior SEC filing
- 06 Mar 2023
- Next SEC filing
- 06 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark Eisner filed Form 4 for FIBROGEN INC (FGEN) on 10 Mar 2023.
Change
- Previous filing in this sequence was filed on 06 Mar 2023.
- Current net transaction value: -$360,572.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FGEN
transaction
Common Stock
Sale
- Transaction value
- $155,771
- Shares
- -7,363
- Change %
- -4.3%
- Price
- $21.16*
- Shares after
- 165,133
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
FGEN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,732
- Change %
- +4.7%
- Price
- $0.000000
- Shares after
- 172,865
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
FGEN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,451
- Change %
- +7.2%
- Price
- $0.000000
- Shares after
- 185,316
- Date
- 08 Mar 2023
- Ownership
- Direct
- Footnotes
- F3
FGEN
transaction
Common Stock
Sale
- Transaction value
- $78,467
- Shares
- -3,885
- Change %
- -2.1%
- Price
- $20.20*
- Shares after
- 181,431
- Date
- 10 Mar 2023
- Ownership
- Direct
- Footnotes
- F4
FGEN
transaction
Common Stock
Sale
- Transaction value
- $126,334
- Shares
- -6,255
- Change %
- -3.4%
- Price
- $20.20*
- Shares after
- 175,176
- Date
- 10 Mar 2023
- Ownership
- Direct
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
Footnote F2
Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023.
Footnote F3
Represents the number of shares released for PSU TSR Grant vested on March 8, 2023.
Footnote F4
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I.
Footnote F5
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I.